One such case is Pharmasset Inc. (VRUS). Yesterday, the stock rose more than 10% with a volume of shares five times its daily average. The breakout occurs yesterday after two months of consolidation. VRUS seems that a new journey upward.
Visit our site: www.themarkettrust.com
Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Its primary focus is on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection. Pharmasset, Inc. was founded in 1998 and is based in Princeton, New Jersey. (yahoo Finance).
No comments:
Post a Comment